<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">631351</article-id><article-id pub-id-type="doi">10.18565/aig.2023.173</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Kisspeptin in the normal and pathological conditions</article-title><trans-title-group xml:lang="ru"><trans-title>Кисспептин в норме и при патологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0390-3649</contrib-id><name-alternatives><name xml:lang="en"><surname>Tereshchenko</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Терещенко</surname><given-names>Ирина Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr.Med. Sci., Professor, endocrinologist</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, врач-эндокринолог</p></bio><email>i_v_t@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Professorial Clinic</institution></aff><aff><institution xml:lang="ru">МЦ «Профессорская клиника»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-02-29" publication-format="electronic"><day>29</day><month>02</month><year>2024</year></pub-date><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>37</fpage><lpage>43</lpage><history><date date-type="received" iso-8601-date="2024-04-28"><day>28</day><month>04</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-04-28"><day>28</day><month>04</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, ООО «Бионика Медиа»</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/631351">https://journals.eco-vector.com/0300-9092/article/view/631351</self-uri><abstract xml:lang="en"><p>Kisspeptin is a neuropeptide that is produced in the hypothalamus and has a diverse effect on the body. The role of kisspeptin is still under study.</p> <p>The objective of the presented review is to analyze recent publications on the effect of kisspeptin in the body in normal and pathological conditions.</p> <p>The literature search was carried out according to the following criteria: the keyword ‘kisspeptin’ was used, publications were chosen mainly for the last 5 years; Russian literature sources were searched mainly in the publications reviewed by the State Commission for Academic Degrees and Titles, foreign sources were in the databases and services, namely PubMed, Google, and Scope.</p> <p>Kisspeptin has been shown to stimulate the production of gonadotropin-releasing hormone of the hypothalamus and cause its pulsating secretion. In normal conditions, it initiates the onset of puberty, causes the development of egg cells, ovulation in women, high-quality spermatogenesis in men; moreover, it participates in conception, implantation of a fertilized egg, embryo development, placentation, provides energy homeostasis in a pregnant woman, childbirth. During pregnancy, kisspeptin is also produced by the placenta. Kisspeptin secretion is impaired in polycystic ovary syndrome, endometriosis, obesity, pregnancy complications (preeclampsia, gestational diabetes mellitus, risk of miscarriage). The role of kisspeptin in carcinogenesis is studied. Anorexigenic properties of kisspeptin have been revealed. The review includes a description of the synthesized drugs of kisspeptin and its receptor agonists.</p> <p><bold>Conclusion</bold><bold>:</bold> In the future, it is possible to use kisspeptin in the treatment of anovulation, infertility, hypogonadism, obesity, pregnancy complications, non-alcoholic fatty liver disease and probably cancer.</p></abstract><trans-abstract xml:lang="ru"><p>Кисспептин представляет собой нейропептид, который вырабатывается в гипоталамусе и оказывает многообразное действие на организм. Роль кисспептина продолжает изучаться.</p> <p>Цель представленного обзора литературы – проанализировать публикации преимущественно последних лет о действии кисспептина в организме в норме и при патологии.</p> <p>Поиск литературы осуществляли по следующим критериям: использовалось ключевое слово «кисспептин», выбирали публикации преимущественно за последние 5 лет; отечественные источники – в основном в изданиях, рецензируемых ВАК, иностранные – в поисковых системах PubMed, Google, Scope.</p> <p>Показано, что кисспептин стимулирует продукцию гонадотропин-рилизинг-гормона гипоталамуса и вызывает пульсирующую его секрецию. В норме он инициирует начало полового созревания, вызывает развитие яйцеклеток, овуляцию у женщин, качественный сперматогенез у мужчин, участвует в зачатии, имплантации оплодотворенной яйцеклетки, развитии эмбриона, плацентации, обеспечивает энергетический гомеостаз у беременной, роды. При вынашивании беременности кисспептин также вырабатывается плацентой. Секреция кисспептина нарушена при синдроме поликистозных яичников, эндометриозе, ожирении, осложнениях беременности (преэклампсии, гестационном сахарном диабете, риске невынашивания). Изучается роль кисспептина в канцерогенезе. Выявлены анорексигенные свойства кисспептина. Дано описание синтезированных лекарственных препаратов кисспептина и агонистов его рецепторов.</p> <p><bold>Заключение:</bold> В перспективе возможно применение препаратов кисспептина для лечения ановуляции, бесплодия, гипогонадизма, ожирения, осложнений беременности, неалкогольной жировой болезни печени и, возможно, рака.</p></trans-abstract><kwd-group xml:lang="en"><kwd>kisspeptin</kwd><kwd>luliberin</kwd><kwd>gonadotropins</kwd><kwd>estrogens</kwd><kwd>puberty</kwd><kwd>menopause</kwd><kwd>hypothalamus</kwd><kwd>reproduction</kwd><kwd>fertility</kwd><kwd>metabolism</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>кисспептин</kwd><kwd>люлиберин</kwd><kwd>гонадотропины</kwd><kwd>эстрогены</kwd><kwd>половое созревание</kwd><kwd>климакс</kwd><kwd>гипоталамус</kwd><kwd>репродукция</kwd><kwd>фертильность</kwd><kwd>метаболизм</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Tsutsui K., Bentley G.E., Kriegsfeld L.J., Osugi T., Seong J.Y., Vaudry H. Discovery and evolutionary history of GnIH and kisspeptin: new key neuropeptides controlling reproduction. J. Neuroendocrinol. 2010; 22(7): 716-27. https://dx.doi.org/10.1111/j.1365-2826.2010.02018.x.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Padda J., Khalid K., Moosa A., Syam M., Kakani V., Imdad U. et al. Role of kisspeptin on hypothalamic-pituitary-gonadal pathology and its effect on reproduction. Cureus. 202; 13(8): e17600. https://dx.doi.org/10.7759/cureus.17600.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Roseweir A.K., Millar R.P. The role of kisspeptin in the control of gonadotrophin secretion. Hum. Reprod. Update. 2009; 15(2): 203-12. https://dx.doi.org/ 10.1093/humupd/dmn058.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Xie Q., Kang Y., Zhang C., Xie Y., Wang C., Liu C. et al. The role of kisspeptin in the control of the hypothalamic-pituitary-gonadal axis and reproduction. Front. Endocrinol. (Lausanne). 2022; 13: 925206. https://dx.doi.org/10.3389/fendo.2022.925206.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Sobrino V., Avendaño M.S., Perdices-López C., Jimenez-Puyer M., Tena-Sempere M. Kisspeptins and the neuroendocrine control of reproduction: Recent progress and new frontiers in kisspeptin research. Front. Neuroendocrinol. 2022; 65: 100977. https://dx.doi.org/10.1016/j.yfrne.2021.100977.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hrabovszky E., Ciofi P., Vida B., Horvath M.C., Keller E., Caraty A. et al. The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur. J. Neurosci. 2010; 31(11): 1984-98. https://dx.doi.org/10.1111/ j.1460-9568.2010.07239.x.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sharma B., Koysombat K., Comninos A.N., Dhillo W.S., Abbara A. Use of kisspeptin to trigger oocyte maturation during in vitro fertilization (IVF) treatment. Front. Endocrinol. (Lausanne). 2022; 13: 972137. https://dx.doi.org/10.3389/fendo.2022.972137.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kavanagh G.S., Tadi J., Balkenhol S.M., Kauffman A.S., Maloney S.K., Smith J.T. Kisspeptin impacts on circadian and ultradian rhythms of core body temperature: Evidence in kisspeptin receptor knockout and kisspeptin knockdown mice. Mol. Cell. Endocrinol. 2022; 542: 111530. https://dx.doi.org/10.1016/j.mce.2021.111530.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Никитина И.Л., Байрамов А.А., Ходулева Ю.Н., Шабанов П.Д. Кисспептины в физиологии и патологии полового развития - новые диагностические и терапевтические возможности. Обзоры по клинической фармакологии и лекарственной терапии. 2014; 12(4): 3-13. [Nikitina I.L., Bayramov A.A., Khoduleva Yu.N., Shabanov P.D. Kisspeptins in the physiology and pathology of sexual development - new diagnostic and therapeutic possibilities. Reviews on Clinical Pharmacology and Drug Therapy. 2014; 12(4): 3-13. (in Russian)].</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Никитина И.Л., Юхлина Ю.Н., Васильева Е.Ю., Нагорная И.И. Кисспептиновые механизмы регуляции полового развития мальчиков: потенциал диагностики и терапии при задержке старта пубертата и гипогонадотропном гипогонадизме. Проблемы эндокринологии. 2018; 64(5): 280-5. [Nikitina I.L., Yukhlina Yu.N., Vasilyeva E.Yu., Nagornaya I.I. Kisspeptin mechanisms of regulation of sexual development in boys: the potential for diagnosis and therapy in delayed onset of puberty and hypogonadotropic hypogonadism. Problems of Endocrinology. 2018; 64(5): 280-5. (in Russian)]. https://dx.doi.org/10.14341/probl9360.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bhattacharya M., Babwah A.V. Kisspeptin: beyond the brain. Endocrinology. 2015; 156(4): 1218-27. https://dx.doi.org/10.1210/en.2014-1915.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Nagy Z., Herbison A., Kwakowsky A., Kovacs G., Barabas K. Editorial: Estrogen effects on fertility and neurodegeneration - classical versus non-classic al actions. Front. Endocrinol. (Lausanne). 2023; 14: 1192671. https://dx.doi.org/10.3389/fendo.2023.1192671.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Clarke H., Dhillo W.S., Jayasena C.N. Comprehensive review on kisspeptin and its role in reproductive disorders. Endocrinol. Metab. (Seoul). 2015; 30(2): 124-41. https://dx.doi.org/10.3803/EnM.2015.30.2.124.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Jayasena C.N., Nijher G.M.K., Comninos A.N., Abbara A., Januszewki A., Vaal M.L. et al. The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J. Clin. Endocrinol. Metab. 2011; 96(12): E19639-72. https://dx.doi.org/10.1210/jc.2011-140.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Moalla M., Kacem F.H., Al-Mutery A.F., Mahfood M., Mejdoub-Rekik N., Abid M. et al. Nonstop mutation in the Kisspeptin 1 receptor (KISS1R) gene causes normosmic congenital hypogonadotropic hypogonadism. J. Assist. Reprod. Genet. 2019; 36(6): 1273-80. https://dx.doi.org/10.1007/s10815-019-01468-z.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Abbara A., Eng P.C., Phylactou M., Clarke S.A., Mills E., Chia G. et al. Kisspeptin-54 accurately identifies hypothalamic gonadotropin-releasing hormone neuronal dysfunction in men with congenital hypogonadotropic hypogonadism. Neuroendocrinology. 2021; 111(12): 1176-86. https://dx.doi.org/10.1159/000513248.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Chelaghma N., Rajkanna J., Trotman J., Fuller G., Elsey T., Park S.M., Oyibo S.O. Normosmic idiopathic hypogonadotrophic hypogonadism due to a rare KISS1R gene mutation. Endocrinol. Diabetes Metab. Case Rep. 2018; 2018: 18-0028. https://dx.doi.org/10.1530/EDM-18-0028.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Valdes-Socin H., Almanza M.R., Fernández-Ladreda M.F., Debray F.G., Bours V., Beckers A. Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Front. Endocrinol. (Lausanne). 2014; 5: 109. https://dx.doi.org/10.3389/fendo.2014.00109.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Pagani S., Calcaterra V., Acquafredda G., Montalbano C., Bozzola E., Ferrara P. et al. MKRN3 and KISS1R mutations in precocious and early puberty. Ital. J. Pediatr. 2020; 46: 39. https://doi.org/10.1186/s13052-020-0808-6.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Tang R., Ding X., Zhu J. Kisspeptin and polycystic ovary syndrome. Front. Endocrinol. (Lausanne). 2019; 10: 298. https://dx.doi.org/10.3389/fendo.2019.00298.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Wang T., Han S., Tian W., Zhao M., Zhang H. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Gynecol. Endocrinol. 2019; 35(9): 807-10. https://dx.doi.org/10.1080/ 09513590.2019.1597343.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Pérez-López F.R., Ornat L., López-Baena M.T., Santabárbara J., Savirón-Cornudella R., Pérez-Roncero G.R. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 260: 85-98. https://dx.doi.org/10.1016/ j.ejogrb.2021.03.007.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Akad M., Socolov R., Covali R., Stan C.D., Crauctuc E., Popovici D. et al. Kisspeptin serum levels in patients with endometriosis, new research pathways regarding female infertility. Maedica (Bucur.). 2022; 17(3): 557-60. https://dx.doi.org/10.26574/maedica.2022.17.3.557.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Asare-Anane H., Ofori E.K., Kwao-Zigah G., Ateko R.O., Annan B.D.R.T., Adjei A.B. et al. Lower circulating kisspeptin and primary hypogonadism in men with type 2 diabetes. Endocrinol. Diabetes Metab. 2019; 2(3): e00070. https://dx.doi.org/10.1002/edm2.70.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Sithinamsuwan K., Mahachoklertwattana P., Wankanit S., Chanprasertyothin S., Pongratanakul S., Khlairit P. et al. Serum kisspeptin and its relation to metabolic parameters and glucose metabolism in prepubertal and pubertal obese children. J. Endocrinol. 2020; 10: 8826401. https://dx.doi.org/10.1155/2020/8826401.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>De Bond J.A., Smith J.T. Kisspeptin and energy balance in reproduction. Reproduction. 2014; 147(3): R53-63. https://dx.doi.org/10.1530/REP-13-0509.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Shalitin S., Gat-Yablonski G. Associations of obesity with linear growth and puberty. Horm. Res. Paediatr. 2022; 95(2): 120-36. https://dx.doi.org/ 10.1159/000516171.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Adams J., Franks S., Polson D.W., Mason H.D., Abdulwahid N., Tucker M. et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet. 1985; 2(8469-70): 1375-9. https://dx.doi.org/10.1016/s0140-6736(85)92552-8.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Воднева Д.Н., Шмаков Р.Г., Щеголев А.И. Роль маркеров инвазии трофобласта в развитии преэклампсии и опухолевой прогрессии. Акушерство и гинекология. 2013; 11: 9-12. [Vodneva D.N., Shmakov R.G., Shchegolev A.I. Role of markers for trophoblast invasion in the development of preeclampsia and tumor progression. Obstetrics and Gynecology. 2013; (11): 9-12. (in Russian)].</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Tsoutsouki J., Patel B., Comninos A.N., Dhillo W.S., Abbara A. et al. Kisspeptin in the prediction of pregnancy complications. Front. Endocrinol. (Lausanne). 2022; 13: 942664. https://dx.doi.org/10.3389/fendo.2022.942664.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Matsui H., Asami T. Effects and therapeutic potentials of kisspeptin analogs: regulation of the hypothalamic-pituitary-gonadal axis. Neuroendocrinology. 2014; 99(1): 49-60. https://dx.doi.org/10.1159/000357809.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Hu K.L., Chen Z., Li X., Cai E., Yang H., Chen Y. et al. Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reprod. Biol. Endocrinol. 2022; 20(1): 81. https://dx.doi.org/10.1186/ s12958-022-00953-y.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Lippincott M.F., Chan Y.-M., Morales D.R., Seminara S.B. Continuous kisspeptin administration in postmenopausal women: impact of estradiol on luteinizing hormone secretion. J. Clin. Endocrinol. Metab. 2017;102(6): 2091-9. https://dx.doi.org/10.1210/jc.2016-3952.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Navarro V.M. Metabolic regulation of kisspeptin - the link between energy balance and reproduction. Nat. Rev. Endocrinol. 2020; 16(8): 407-20. https://dx.doi.org/10.1038/s41574-020-0363-7.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Hestiantoro A., Astuti B.P.K., Muharam R., Pratama G., Witjaksono F., Wiweko B. Dysregulation of kisspeptin and leptin, as anorexigenic agents, plays role in the development of obesity in postmenopausal women. Int. J. Endocrinol. 2019; 2019: 1347208. https://dx.doi.org/10.1155/2019/ 1347208.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Abbas S.J., Abed F.S., Dhefer I.H. Does kisspeptin act as a neuropeptide or as an adipokine in obese people? J. Taibah. Univ. Med. Sci. 2022; 17(1): 45-50. https://dx.doi.org/10.1016/j.jtumed.2021.07.010.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Rashad N.M., Al-Sayed R.M., Yousef M.S., Saraya Y.S. Kisspeptin and body weight homeostasis in relation to phenotypic features of polycystic ovary syndrome; metabolic regulation of reproduction. Diabetes Metab. Syndr. 2019; 13(3): 2086-92. https://dx.doi.org/10.1016/ j.dsx.2019.04.017.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Izzi-Engbeaya C., Choudhury M.M., Patel B., Muzi B., Qayuum A., Mills E.G. The effects of kisspeptin on food intake in women with overweight or obesity. Diabetes Obes. Metab. 2023; 25(8): 2393-7. https://dx.doi.org/10.1111/dom.15086.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Shamas S., Rani S., Afsheen S., Shahab M., Ejaz R., Sadia H. et al. Changes in irisin release in response to peripheral kisspeptin-10 administration in healthy and obese adult men. Acta Endocrinol. (Buchar.). 2019; 15(3): 283-8. https://dx.doi.org/10.4183/aeb.2019.283.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Wolfe A., Hussain M.A. The emerging role(s) for kisspeptin in metabolism in mammals. Front. Endocrinol. (Lausanne). 12018; 9: 184. https://dx.doi.org/ 10.3389/fendo.2018.00184.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Huang C., Wang H.Y., Wang M.E., Hsu M.C., Wu Y.S., Jiang Y.F. et al. Kisspeptin-activated autophagy independently suppresses non-glucose-stimulated insulin secretion from pancreatic β-cells. Sci. Rep. 2019; 9(1): 17451. https://dx.doi.org/10.1038/s41598-019-53826-7.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Маевская М.В., Ивашкин В.Т., Ивашкин К.В., Луньков В.Д., Люсина Е.О., Зозюля В.Н., Лещенко В.И. Неалкогольная жировая болезнь печени как причина и следствие кардиометаболических осложнений. Особенности фармакотерапии. Место урсодезоксихолевой кислоты. Терапевтический Архив. 2019;91(2): 109-17. [Maevskaya M.V., Ivashkin V.T., Ivashkin K.V., Lunkov V.D., Lyusina E.O. Non-alcoholic fatty liver disease as a cause and consequence of cardiometabolic complications. Features of pharmacotherapy. Location of ursodeoxycholic acid. Therapeutic Archive. 2019; 91((2): 109-17. (in Russian)]. https://dx.doi.org/10.26442/00403660.2019.02.000122.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Guzman S., Dragan M., Kwon H., de Oliveira V., Rao S., Bhatt V. et al. Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model. J. Clin. Invest. 2022; 132(10): e145889. https://dx.doi.org/ 10.1172/JCI145889.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Ly T., Harihar S., Welch D.R. KISS1 in metastatic cancer research and treatment: potential and paradoxes. Cancer Metastasis Rev. 2020; 39(3): 739-54. https://dx.doi.org/10.1007/s10555-020-09868-9.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Dragan M., Nguyen M.-U., Guzman S., Goertzen C., Brackstone M., Dhillo W.S. et al. G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer. Cell. Death Dis. 2020; 11(2): 106. https://dx.doi.org/10.1038/ s41419-020-2305-7.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Gowkielewicz M., Lipka A., Piotrowska A., Szadurska-Noga M., Nowakowski J.J., Lepiarczyk E. et al. Kisspeptin and GPR54 receptor expression in endometrial cancer tissue. Cancers (Basel). 2023; 15(4): 1228. https://dx.doi.org/10.3390/cancers15041228.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Kim T.H., Cho S.G. Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2. Mol. Med. Rep. 2017; 16(5): 7585-90. https://dx.doi.org/ 10.3892/mmr.2017.7578.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Ciaramella V., Corte C.M.D., Ciardiello F., Morgillo F. Kisspeptin and cancer: molecular interaction, biological functions, and future perspectives. Front. Endocrinol. (Lausanne). 2018; 9: 115. https://dx.doi.org/10.3389/fendo.2018.0011.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Ulasov I.V., Borovjagin A.V., Timashev P., Cristofanili M., Welch D.R. KISS1 in breast cancer progression and autophagy. Cancer Metastasis Rev. 2019; 38(3): 493-506. https://dx.doi.org/10.1007/s10555-019-09814-4.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Guzman S., Brackstone M., Radovick S., Babwah A.V., Bhattacharya M.M. KISS1/KISS1R in cancer: friend or foe? Front. Endocrinol. (Lausanne). 2018; 9: 437. https://dx.doi.org/10.3389/fendo.2018.00437.</mixed-citation></ref></ref-list></back></article>
